Does anyone have experience obtaining sunvozertinib in the second-line setting for patients with EGFR exon 20 insertion mutations?

I have not. Though FDA-approved for months, the drug has not been available for dispensation. Dizal has not had a US presence and has not yet established a distribution partnership. Currently available in China - hoping for access in the US any day now.

We had the sunvozertinib study open at our site. We were able to access the drug through an expanded access program, but this has been discontinued. Even though the FDA has approved it, the distribution network within the US remains very limited, but hopefully, this will change within the year. Pati...